# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Dehydratase Deficiency

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-3 of 3 results.
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Status: Terminated
Last Changed: Jan 25, 2019
First Received: Jun 06, 2018
Disease(s): Acute Hepatic Porphyria, Hepatic Porphyrias, Acute Intermittent Porphyria (AIP), Hereditary Coproporphyria (HCP), Variegate Porphyria (VP), ALA Dehydratase Deficient Porphyria (ADP), Porphyria Acute
Locations: Clinical Trial Site, Pasadena, California, United States
Clinical Trial Site, Jacksonville, Florida, United States
Clinical Trial Site, Margate, Florida, United States
Clinical Trial Site, Ames, Iowa, United States
Clinical Trial Site, Las Vegas, Nevada, United States
... and 8 other locations.
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
Status: Active, not recruiting
Last Changed: Dec 13, 2019
First Received: Nov 09, 2017
Disease(s): Acute Hepatic Porphyria, Acute Intermittent Porphyria, Porphyria, Acute Intermittent, Acute Porphyria, Hereditary Coproporphyria (HCP), Variegate Porphyria (VP), ALA Dehydratase Deficient Porphyria (ADP)
Intervention(s): Givosiran, Placebo
Locations: Clinical Trial Site, Little Rock, Arkansas, United States
Clinical Trial Site, San Francisco, California, United States
Clinical Trial Site, Miami, Florida, United States
Clinical Trial Site, Boston, Massachusetts, United States
Clinical Trial Site, Ann Arbor, Michigan, United States
... and 38 other locations.
Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria
Status: Available
Last Changed: Jan 18, 2020
First Received: Aug 14, 2019
Disease(s): Acute Hepatic Porphyria
Intervention(s): Givosiran
Locations: Program Site, Brussels, Belgium
Program Site, Colombes, France
Program Site, Berlin, Germany
Program Site, Chemnitz, Germany
Program Site, Rotterdam, Netherlands
... and 2 other locations.